For decades, statistical analysis has remained one of clinical research's most manual processes. As AI reshapes drug ...

University of Alberta researchers have developed a new statistical tool to evaluate the results of clinical trials, with the aim of allowing smaller trials to ask more complex research questions and ...

New FDA guidance on the use of Bayesian statistics signals a broader shift in accommodating more flexible clinical trial ...

The statistical methods scientists use to analyze outcomes from clinical trials in amyotrophic lateral sclerosis (ALS) vary widely, and these differences may make some trials prone to generating ...

Statistical fragility refers to the vulnerability of clinical trial results to minor changes in event outcomes. The fragility index quantifies this vulnerability by determining the minimum number of ...

The most underestimated category, and the one with the most long-term potential, is clinical-driven AI, where the model is trained to interpret clinical data the way a researcher with a PhD or a ...

In a new draft guidance issued on January 14, 2026, the FDA discussed the use of a modern statistical methodology in clinical trials designed to show the effectiveness of a new drug. The guidance, ...

DUBLIN--(BUSINESS WIRE)--The "Clinical Trials Market Forecast Report by Phase, Indication, Study Material, Country and Company 2025-2033" report has been added to ResearchAndMarkets.com's offering.

Wearable sensors remain largely underused, despite their utility in improving data collection and regulatory compliance.

Kivo reports on the top 5 diseases affecting men, highlighting disparities in health, the urgency of clinical trials, and the ...